¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nonspecific low blood-pressure reading"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonspecific
    ºñƯÀÌ-
  • nonspecific immunity
    ºñƯÀ̸鿪
  • nonspecific immunosuppression
    ºñƯÀ̸鿪¾ïÁ¦
  • nonspecific reaction
    ºñƯÀ̹ÝÀÀ
  • nonspecific urethritis
    ºñƯÀ̿䵵¿°
  • bar reading
    ¸·´ë°¡¸²Àбâ
  • keratometry reading
    °¢¸·°î·üÃøÁ¤ÆÇµ¶
  • lip reading
    µ¶¼ø¼ú(ÔÁâîâú), ÀÔ¼úÀбâ
  • open reading frame
    ÇØµ¶Æ²
  • overlapping reading frame
    Áߺ¹Çص¶Æ²
  • reading
    ÆÇµ¶, Àбâ
  • reading disorder
    ÀбâÀå¾Ö
  • reading glasses
    µ¶¼­¾È°æ, ³ë¾È°æ
  • reading impairment
    Àбâ¼Õ»ó
  • reading quotient
    µ¶¼­Áö¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonspecific
    ºñƯÀÌ-, ºñƯ¼ö-
  • reading disorder
    ÀбâÀå¾Ö
  • reading
    ÆÇµ¶, Àбâ
  • reading spectacles
    µ¶¼­¾È°æ, ³ë¾È°æ
  • low fever
    ¹Ì¿­
  • low risk group
    ÀúÀ§Ç豺
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
  • low potency
    ÀúÈ¿´É, Àú¿ª°¡, ÀúÀáÀç·Â
  • low signal
    ¾àÇѽÅÈ£, Àú½ÅÈ£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonspecific immunity
    ºñƯÀ̸鿪
  • nonspecific
    ºñƯÀÌ-, ºñƯ¼ö-
  • nonspecific reaction
    ºñƯÀ̹ÝÀÀ
  • nonspecific urethritis
    ºñƯÀ̿䵵¿°
  • nonspecific sensory system
    ºñƯÁ¤°¨°¢°è
  • bar reading
    ¸·´ë°¡¸²Àбâ
  • reading disorder
    ÀбâÀå¾Ö
  • specific reading disability
    ƯÁ¤ÀбâÀå¾Ö
  • open reading frame
    ÇØµ¶Æ²
  • overlapping reading frame
    Áߺ¹Çص¶Æ²
  • reading glasses
    µ¶¼­¾È°æ, ³ë¾È°æ
  • reading impairment
    Àбâ¼Õ»ó
  • keratometry reading
    °¢¸·°î·üÃøÁ¤Ä¡
  • lip reading
    ¼øµ¶¹ý, ÀÔ¼úÀбâ
  • reading frame mutation
    ÇØµ¶Æ²µ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunity, nonspecific
    ºñƯÀ̸鿪
  • reading
    ÆÇµ¶
  • Castellani-Low symptom
    Ä«½ºÅÚ¶ó´Ï-·Î¿ìÁõ»ó.
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • frequency deafness, low
    ÀúÁ֯ijó, ÀúÁÖÆÄ±Í¸ÔÀ½
  • hellp(hemolysis, elevated liver enzymes, low platelet),heliminths
    À±Ãæ(ëÌõù)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic nonspecific dermatitis
    ¸¸¼º ºñƯÀ̼º ÇǺο°
  • immunity, nonspecific
    ºñƯÀ̸鿪
  • nonspecific
    ºñƯÀ̼º
  • nonspecific gastritis
    ºñƯÀ̼º À§¿°(~êÖæú).
  • nonspecific gastritis
    ºñƯÀ̼º À§¿°(Þª÷åì¶àõêÖæú)
  • nonspecific immunity
    ºñƯÀ̼º ¸é¿ª(~Øóæ¹).
  • nonspecific nuclei
    ºñƯ¼öÇÙ.
  • nonspecific protein therapy
    ºñƯÀ̼º ´Ü¹é¿ä¹ý.
  • nonspecific reaction
    ºñƯÀ̹ÝÀÀ.
  • nonspecific sensory system
    ºñƯÁ¤°¨°¢°è
  • nonspecific thalamocortical projection nuclei
    ºñƯ¼ö½Ã»óÇÇÁúÅõ»çÇÙ?Þª÷åâ¨ãÊßÉù«òõ÷âÞÒú·ÏØ).
  • nonspecific ulcerative colitis
    ºñƯÀÌ(¼º) ±Ë¾ç¼º °áÀå¿°(~Ï÷åËàõÌ¿ æú).
  • nonspecific ulcerative colitis
    ºñƯÀÌ(¼º) ±Ë¾ç¼º °áÀå¿°(¡­ÝïÏ÷åËàõÌ¿ æú)
  • nonspecific urethritis
    ºñƯÀ̼º ¿äµµ¿°(~èñÔ³æú).
  • serotonin-nonspecific reuptake inhibito£ò
    ºñƯÁ¤¼º ¼¼·ÎÅä´Ñ ÀçÈí¼ö¾ïÁ¦Á¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonspecific immunity
    ºñƯÀÌ ¸é¿ª(Þª÷åì¶Øóæµ)
  • closed reading frame
    ´ÝÈù µ¶ÇØ(ÔÁú°)Ʋ
  • frame of reading
    µ¶ÇØ(ÔÁú°)Ʋ
  • open reading frame
    ¿­¸° ¹ø¿ª(Ûèæ»)Ʋ
  • reading
    ÆÇµ¶(÷÷ÔÁ)
  • reading frame
    ÆÇµ¶(÷÷ÔÁ)Ʋ
  • reading frameshift
    ÆÇµ¶(÷÷ÔÁ)ƲÀ̵¿(ÔÁì¹ÔÑ)
  • reading mistake
    ÆÇµ¶ ¿À·ù(÷÷ÔÁè¦×½)
  • low-angle x-ray diffraction
    ¼Ò°¢(á³ÊÇ) X-¼±È¸Àý(àÊüÞï¹)
  • low background counter
    ³·Àº¹ÙÅÁ °è¼ö±â(ͪâ¦Ðï)
  • low-copy number
    Àú(î¸)Ä«ÇǼö(â¦)
  • low-density fraction
    Àú¹ÐµµºÐȹ(î¸ÚËÓøÝÂüñ)
  • low-density lipoprotein
    Àú¹Ðµµ Áö´Ü¹éÁú(î¸ÚËÓøò·Ó±ÛÜòõ)
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • low-energy electron diffraction
    Àú(î¸)¿¡³ÊÁö ÀüÀÚȸÀý(ï³í­üÞï¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reading
    ÆÇµ¶
  • fast Low Angle Shot [=FLASH]
    °í¼ÓÀú°¢¿µ»óȹµæ
  • low attenuation
    ³·Àº °¨¾à
  • low back pain
    ¿äÅë
  • low echo area
    Àú¿¡ÄÚ±¸¿ª
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • low pass filter
    ÀúÅë°ú¿©°ú±â
  • low signal
    Àú½ÅÈ£
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
LF labile factor; lactoferrin; laryngofissure; Lassa fever; latex fixation; left foot; left forearm; le...
LFD lactose-free diet; large for date [fetus]; late fetal death; lateral facial dysplasia; least fatal d...
LFT latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio...
LOR long open reading frame; lorazepam; loricrin; loss of righting reflex
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
nsLTP Nonspecific lipid transfer protein
NCC Nonspecific cytotoxic cell
NSIP Nonspecific interstitial pneumonia
CNPD chronic nonspecific pulmonary disease
NART National Adult Reading Test
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • R03.1
    Nonspecific low blood-pressure reading
    ¸í½ÃµÇÁö ¾ÊÀº ³·Àº Ç÷¾Ð¼öÄ¡
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • low biscuit stage µµÀç ÀÔÀÚ°¡ ¼­·Î ÀÀÁýµÇ³ª ´Ù°ø¼ºÀ̸ç, ºÎ¼­Áö±â ½¬¿î »óÅÂ.

    low blood pressure

    ÀúÇ÷¾Ð
    Ç÷¾Ð°è·Î Àü¿Ï µ¿¸ÆÀÇ Ç÷¾ÐÀ» ÃøÁ¤ÇÏ¿´À» ¶§ Ç÷¾ÐÀÌ Á¤»óº¸´Ù ³·Àº °æ¿ìÀÇ ÃÑĪ. Á¤»ó °ªÀº ¿¬·É, ¼º¿¡ µû¶ó ´Ù¸£Áö¸¸, ´ë°³ ÃÖ°í Ç÷¾ÐÀÌ 100 mmHg ÀÌÇÏÀ̸é ÀúÇ÷¾ÐÀ̶ó°í ÇÑ´Ù. ±×·¯³ª °íÇ÷¾ÐÁõÀÇ »ç¶÷ÀÌ ±Þ°ÝÈ÷ Ç÷¾ÐÀÌ ¶³¾îÁø °æ¿ì´Â Ç÷¾ÐÄ¡°¡ ºñ·Ï Á¤»ó ¹üÀ§¶ó ÇÒÁö¶óµµ ÀúÇ÷¾Ð Áõ¼¼¸¦ ÃÊ·¡ÇÏ´Â ¼ö°¡ ÀÖ´Ù. ÀúÇ÷¾ÐÀ» ÃÊ·¡ÇÏ´Â ÁúȯÀ¸·Î¼­´Â Å©°Ô ¸¸¼º Áö¼Ó¼º ÀúÇ÷¾ÐÁõ°ú ±â¸³¼º ÀúÇ÷¾Ð ¹× ¼îÅ©°¡ ÀÖ´Ù.¡¼¸¸¼º Áö¼Ó¼º ÀúÇ÷¾ÐÁõ¡½ °¢Á¾ÀÇ ½É Áúȯ
  • low-voltage low-amperage biphasic current
    ÀúÀü¾Ð ÀúÀü·ùÀÇ º¹Çü Àü·ù
  • low-voltage, low-amperage, biphasic current
    ÀúÀü¾Ð ÀúÀü·ùÀÇ º¹Çü Àü·ù
  • bar-reading test
    ¹Ù-¸®µù ½ÃÇè
    ¾ç¾È½Ã¿Í ÀÔü ½Ã¿¡ ´ëÇÑ ½ÃÇèÀ¸·Î¼­, ¾çÂÊ ´«°ú ÀμâµÈ ÆäÀÌÁö¿Í »çÀÌ Áß°£Âë¿¡ ÀÚ¸¦ ³õ´Â´Ù. À̰ÍÀº ¶ÇÇÑ ÀÔü½ÃÀÇ ÈÆ·Ã¿¡µµ ÀÌ¿ëµÈ´Ù.
  • lip reading
    µ¶¼ø¼ú
    ¸»ÇÒ ¶§ ÀÔ¼úÀÌ ¿òÁ÷ÀÌ´Â °ÍÀ» º¸°í ¸»ÇÏ´Â ³»¿ëÀ» ¾Ë¾Æ³»´Â °Í.
  • open reading frame
    ÇØµ¶ Ʋ
  • reading framework mutation
    ÆÇµ¶ °ñ°Ý ±¸Á¶ À̵¿ µ¹¿¬º¯ÀÌ
  • chronic nonspecific dermatitis
    ¸¸¼º ºñƯÀ̼º ÇǺο°
  • nonspecific
    ºñƯÀ̼º
    1. Ưº°ÇÑ º´¿øÃ¼¿Í °°Àº ¾î¶² ´ÜÀÏÀÇ ¾Ë·ÁÁø ¿øÀο¡ ÀÇÇÏÁö ¾ÊÀº. 2. ºñƯÀÌ ¿ä¹ý°ú °°ÀÌ Æ¯º°ÇÑ ¿øÀο¡ ´ëÇÑ °ÍÀÌ ¾Æ´Ï°í ÀϹÝÀûÀÎ È¿°ú¸¦ °¡Áø.
  • nonspecific conditioned gingival enlargement
    ºñƯÀ̼º Á¶°Ç¼º Ä¡Àº ºñ´ë
  • nonspecific inflammation
    ºñƯÀ̼º ¿°Áõ
  • nonspecific reaction
    ºñƯÀÌ ¹ÝÀÀ
  • nonspecific sever periodontitis
    ºñƯÀ̼º ÁßÁõ Ä¡ÁÖ¿°
  • nonspecific urethritis
    ºñƯÀ̼º ¿äµµ¿°
  • Castellani-Low symptom
    Ä«½ºÅÚ¶ó´Ï-·Î¿ì Áõ»ó
    ¼ö¸éº´ ȯÀÚ¿¡°Ô¼­ º¼ ¼ö ÀÖ´Â ¼³ ÁøÀü.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
albumin Reading Types of human serum albumin, distinguished by characteristic mobility patterns on electrophoresis; each type is due to a mutation of a gene controlling albumin synthesis; the mutant genes are codominant with the normal gene for albumin A, and the group forms a system of genetic polymorphism; types include: albumin b (slow), found occasionally in persons of European ancestry; albumin Ghent (fast), found first at Ghent, Belgium; albumin Mexico (slow), found in Indians of Mexico and the southwestern United States; albumin Naskapi (fast), found in the Naskapi and other Indians of northern North America; and albumin Reading (fast), found first at Reading, England.
(05 Mar 2000)
blocked reading frame A sequence of DNA that cannot be translated into a viable protein; usually due to the interruption by one or more termination codons.
Synonym: closed reading frame.
(05 Mar 2000)
reading frame One of the three possible ways of reading a nucleotide sequence. As the genetic code is read in nonoverlapping triplets (codons) there are three possible ways of translating a sequence of nucleotides into a protein, each with a different starting point. For example: given the nucleotide sequence: AGCAGCAGC, the three reading frames are: AGC AGC AGC, GCA GCA, CAG CAG.
(18 Nov 1997)
reading frame, open An open reading frame in DNA has no termination codon, no signal to stop reading the nucleotide sequence, and so may be translated into protein.
(12 Dec 1998)
reading frames The sequence of codons by which translation may occur. A segment of mRNA 5'auccga3' could be translated in three reading frames, 5'auc.. Or 5'ucc.. Or 5'ccg.., depending on the location of the start codon.
(12 Dec 1998)
reading-frameshift mutation <molecular biology> A type of mutation that results from insertion or deletion of a single nucleotide into, or from, an open reading frame in the normal DNA sequence.
Normally, the genetic code is read in the wrong frame, three nucleotides at a time, and the entire sequence downstream of the mutation, is translated into a polypeptide with a garbled amino acid sequence from the mutated codon onwards. These mutations may be induced by certain types of mutagens or may occur spontaneously and usually result in the generation, downstream, of nonsense, chain termination codons.
Synonym: addition mutation, addition-deletion mutation, deletion mutation, reading-frameshift mutation.
(21 Jun 2000)
mind-reading The knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes.
(12 Dec 1998)
closed reading frame A sequence of DNA that cannot be translated into a viable protein; usually due to the interruption by one or more termination codons.
Synonym: closed reading frame.
(05 Mar 2000)
open reading frame <molecular biology> A reading frame in a sequence of nucleotides in DNA that contains no termination codons and so can potentially translate as a polypeptide chain.
(18 Nov 1997)
open reading frames Reading frames where successive nucleotide triplets can be read as codons specifying amino acids and where the sequence of these triplets is not interrupted by stop codons.
(12 Dec 1998)
overlapping reading frame <molecular biology> Start codons in different reading frames which generate different polypeptides from the same DNA sequence.
(09 Oct 1997)
unidentified reading frame <molecular biology> A reading frame in a sequence of nucleotides in DNA that contains no termination codons and so can potentially translate as a polypeptide chain.
(18 Nov 1997)
back pain, low Symptoms in the low back can relate to the bony lumbar spine, discs between the vertebrae, ligaments around the spine and discs, spinal cord and nerves, muscles of the low back, internal organs of the pelvis and abdomen, and the skin covering the lumbar area. The low back, or lumbar area, functions in structural support, movement, and protection of certain body tissue.
(12 Dec 1998)
blood sugar, low The sugar here is glucose. Low blood glucose constitutes hypoglycaemia. Hypoglycaemia is only significant when it is associated with symptoms. It has many causes including drugs, liver disease, surgical absence of the stomach, pre-diabetes, and rare tumours that release excess insulin.
(12 Dec 1998)
cardiac output, low A state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular, or pericardial disease.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonspecific
    ÀϹÝÀûÀÎ
  • reading
    µ¶¼­,Àбâ,µ¶º»
  • Reading
    ·¹µù(À×±Û·£µå Áß³²ºÎ BerkshireÁÖÀÇ ¼öµµ,¹Ì±¹ PennsylvaniaÁÖ µ¿³²ºÎÀÇ µµ½Ã)
  • finger reading
    Á¡ÀÚµ¶¹ý !
  • first reading
    Á¦1µ¶È¸
  • lip reading
    (³ó¾ÆÀÚÀÇ)µ¶¼ø¼ú
  • mind reading
    µ¶½É¼ú
  • reading
    µ¶¼­;³¶µ¶;µ¶¼­·Â;(ÀÇȸÀÇ)³¶µ¶È¸;ÇнÃ;¹®ÇлóÀÇ Áö½Ä;ÀÐÀ» °Å¸®;¼±Áý;...µ¶º»;(û¿ì°è.¿Âµµ°è µîÀÇ)Ç¥½Ãµµ¼ö;±â·Ï;(»çº».¿ø°í µîÀÇ)Àд ¹ý(version);(»ç°Ç.²Þ µîÀÇ)ÆÇ´Ü;ÇØ¼®;¿¬Ãâ(¿¬ÁÖ)¹ý;µ¶¼­¿ëÀÇ;µ¶¼­ÇÏ´Â;Ã¥À» ÁÁ¾ÆÇÏ´Â;µ¶¼­ÀÇ;Àбâ À§ÇÑ
  • reading desk
    (¼­¼­ Àбâ À§ÇØ Ç¥¸éÀÌ °æ»çÁø)µ¶¼­´ë;(±³È¸ÀÇ)¼º°æ´ë(lectern)
  • reading glass
    È®´ë°æ;ÀÜ ±ÛÀÚ¿ë ·»Áî;µ¶¼­¿ë ¾È°æ
  • reading lamp
    µ¶¼­¿ë ·¥ÇÁ;¼­Àç¿ë (Àü±â)½ºÅĵå
  • reading list
    (´ëÇеîÀÇ)Ãßõ µµ¼­
  • reading man
    µ¶¼­°¡
  • reading matter
    (½Å¹®.ÀâÁöÀÇ)±â»ç;ÀÐÀ» °Å¸®
  • reading notice
    ±â»ç½Ä ±¤°í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á